ATE163679T1 - Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor - Google Patents

Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor

Info

Publication number
ATE163679T1
ATE163679T1 AT93911148T AT93911148T ATE163679T1 AT E163679 T1 ATE163679 T1 AT E163679T1 AT 93911148 T AT93911148 T AT 93911148T AT 93911148 T AT93911148 T AT 93911148T AT E163679 T1 ATE163679 T1 AT E163679T1
Authority
AT
Austria
Prior art keywords
receptor
vitamin
transcobalamin
blocking agents
growth blocking
Prior art date
Application number
AT93911148T
Other languages
English (en)
Inventor
Alton Charles Morgan Jr
Original Assignee
Receptagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Receptagen Corp filed Critical Receptagen Corp
Application granted granted Critical
Publication of ATE163679T1 publication Critical patent/ATE163679T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93911148T 1992-05-08 1993-05-07 Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor ATE163679T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88054092A 1992-05-08 1992-05-08

Publications (1)

Publication Number Publication Date
ATE163679T1 true ATE163679T1 (de) 1998-03-15

Family

ID=25376514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911148T ATE163679T1 (de) 1992-05-08 1993-05-07 Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor

Country Status (11)

Country Link
US (1) US5688504A (de)
EP (1) EP0644948B1 (de)
JP (1) JPH07508174A (de)
KR (1) KR950701390A (de)
AT (1) ATE163679T1 (de)
AU (1) AU680822B2 (de)
CA (1) CA2135277C (de)
DE (1) DE69317282D1 (de)
NO (1) NO944247L (de)
NZ (1) NZ252559A (de)
WO (1) WO1993023557A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416728B2 (en) 1992-05-08 2008-08-26 Kyto Biopharma, Inc. Growth blocking agents
US5739287A (en) * 1994-04-08 1998-04-14 University Of Washington Biotinylated cobalamins
US5840880A (en) * 1994-04-08 1998-11-24 Receptagen Corporation Receptor modulating agents
US5869465A (en) * 1994-04-08 1999-02-09 Receptagen Corporation Methods of receptor modulation and uses therefor
DE69528523T2 (de) * 1994-04-08 2003-06-12 Receptagen Corp., Edmonds Rezeptor modulierendes mitteln und entsprechendes verfahren
ATE318844T1 (de) * 1994-09-13 2006-03-15 Kyto Biopharma Inc Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
WO1997014711A1 (en) * 1995-10-19 1997-04-24 Receptagen Corporation Vitamin b12 receptor modulating agents and methods related thereto
US20020102258A1 (en) * 1997-05-12 2002-08-01 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (TR2) antibodies
WO1998051346A1 (en) * 1997-05-12 1998-11-19 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (tr2) antibodies
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
GB9820473D0 (en) * 1998-09-18 1998-11-11 Axis Biochemicals Asa Assay
US6492497B1 (en) * 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
CA2441228A1 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US20040047917A1 (en) * 2002-09-06 2004-03-11 Stephen Wilson Drug delivery and targeting with vitamin B12 conjugates
JP2008513536A (ja) 2004-09-22 2008-05-01 レセプター バイオロジックス インコーポレイテッド プロガストリンに対するモノクローナル抗体
US20080015194A1 (en) * 2006-01-23 2008-01-17 Joseph Errico Methods and compositions of targeted drug development
JP5524610B2 (ja) 2006-04-07 2014-06-18 ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
WO2025219395A1 (en) 2024-04-16 2025-10-23 Chu D'angers Treatment of cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
JPS633262A (ja) * 1986-06-24 1988-01-08 Toshiba Corp 網状赤血球の分析方法及び装置

Also Published As

Publication number Publication date
AU4239193A (en) 1993-12-13
DE69317282D1 (de) 1998-04-09
EP0644948B1 (de) 1998-03-04
NO944247D0 (no) 1994-11-07
CA2135277A1 (en) 1993-11-25
AU680822B2 (en) 1997-08-14
NZ252559A (en) 1996-10-28
EP0644948A1 (de) 1995-03-29
US5688504A (en) 1997-11-18
CA2135277C (en) 2001-04-24
JPH07508174A (ja) 1995-09-14
WO1993023557A1 (en) 1993-11-25
NO944247L (no) 1995-01-09
KR950701390A (ko) 1995-03-23

Similar Documents

Publication Publication Date Title
DE69317282D1 (de) Anti-Rezeptor Antikörper gegen den Vitamin B12/transcobalamin II Rezeptor
DK0873340T3 (da) Heterocyklisk substituerede cyclopentanforbindelser
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
EA199700280A1 (ru) Ингибиторы протеинкиназы с
ES2146774T3 (es) Polimeros de ioneno que contienen aniones biologicamente activos.
DE69433406T2 (de) Antikörper gegen cd40
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
AR001413A1 (es) Compuestos triciclicos de carbamato, utiles para la inhibición de la función de la proteina g y paratratamiento de enfermedades proliferativas.
BR0114646A (pt) anticorpos anti-lt-beta-r humanizados
FI960567A0 (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ATE318844T1 (de) Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
DE60007120D1 (de) Isophosphoramide-senfgasanalogen und deren verwendung
PT952975E (pt) Compostos bi-aromaticos ligados por um radical hetero-etinileno e composicoes farmaceuticas e cosmeticas que os contem
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
TR199701298T1 (xx) Tetralinler.
FR2694628B1 (fr) Cellule photo-electrique, notamment submersible, et attache rapide pour sa fixation sur une source de lumiere ultraviolette.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
ATE217619T1 (de) Endothelin-rezeptor-antagonisten
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung